Lifetime Comorbidity of DSM-IV Mood and Anxiety Disorders and Specific Drug Use Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To present nationally representative data on the lifetime prevalence and comorbidity of 8 specific drug use disorders, separately for abuse and dependence, and mood and anxiety disorders. METHOD: Data come from a representative sample (N=43,093) of the United States civilian, noninstitutional population 18 years and older. Diagnoses of mood, anxiety, and drug use disorders were based upon face-to-face personal interviews using the Alcohol Use Disorder and Associated Disabilities Interview Schedule-DSM-IV Version (AUDADIS-IV). RESULTS: Associations between specific mood and anxiety disorders and specific drug use disorders were virtually all positive and statistically significant (p<.05). In general, associations were greater for dependence than abuse, greater for mood than anxiety disorders, and in some instances stronger among women than men (p<.05). Large odds ratios also were observed for individuals with comorbid mood and anxiety disorders. CONCLUSION: The comorbidity between specific mood and anxiety disorders and specific drug use disorders is pervasive in the U.S. population. Findings suggest that comorbid psychiatric disorders may increase the risk of greater involvement in more serious illicit drug use disorders and that the greater comorbidity between mood and anxiety and drug use disorders among women may reflect greater deviance and psychopathology among drug-using women than men. Findings also suggest that drug abuse prevention and intervention efforts should address other psychiatric conditions. Further, definitions of drug use disorder phenotypes should give careful consideration to other psychiatric conditions as meaningful characteristics of case heterogeneity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Anxiety disorders are highly comorbid with substance use disorders [43]”
From Correlates of Quality of Life in Anxiety Disorders: Review of Recent Research (2021) · cites this paper as [43]
In the citing paper
“relapse for SUD, experience increased distress, internalized stigma, lower quality of life, and a higher likelihood of using multiple substances than people diagnosed with SUD alone(Carpentier et al., 2009; Chang et al., 2019; Conway et al., 2006; Lejuez et al., 2008; Rogers et al., 2019).”
From A systematic review and meta-analysis of psychosocial interventions for persons with comorbid anxiety and substance use disorders (2024) · cites this paper as Conway et al., 2006
In the citing paper
“GAD, PD, agoraphobia, social phobia, and specific phobias are often found to be highly co-morbid with each other as well as other psychiatric disorders including depression, PTSD, and substance-use disorders (Conway et al, 2006;Kaufman and Charney, 2000;Regier et al, 1998).”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Conway et al, 2006
In the citing paper
“Furthermore, gambling disorder frequently co-occurs with substance use disorders, particularly alcohol and nicotine, as well as mood and anxiety disorders (Conway, Compton, Stinson, & Grant, 2006; B. F. Grant et al., 2004b; Petry et al., 2005; Ronzitti, Kraus, Hoff, & Potenza, 2018).”
From Cued for Risk: Evidence for an Incentive Sensitization Framework to Explain the Interplay between Stress and Anxiety, Substance Abuse, and Reward Uncertainty in Disordered Gambling Behavior (2019) · cites this paper as Conway, Compton, Stinson, & Grant, 2006
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
Smoking and Mental Illness: A Population-Based Prevalence Study
Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000) · JAMA · doi:10.1001/jama.284.20.2606 · Cited by 2,508
Kessler, R. C. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830160031005 · Cited by 2,085
Kessler, R. C., Nelson, C. B., McGonagle, K. A., Edlund, M. J., Frank, R. G., & Leaf, P. J. (1996) · American Journal of Orthopsychiatry · doi:10.1037/h0080151 · Cited by 1,378
Grant, B. F., Dawson, D. A., Stinson, F. S., Chou, P. S., Kay, W., & Pickering, R. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00070-x · Cited by 1,110
Self-citationHelzer, J. E., & Pryzbeck, T. R. (1988) · Journal of Studies on Alcohol · doi:10.15288/jsa.1988.49.219 · Cited by 1,081
Comorbidity of substance use disorders with mood and anxiety disorders
Merikangas, K. R., Mehta, R. L., Molnar, B. E., Walters, E. E., Swendsen, J. D., Aguilar-Gaziola, S., Bijl, R., Borges, G., Caraveo-Anduaga, J. J., Dewit, D. J., et al. (1998) · Addictive Behaviors · doi:10.1016/s0306-4603(98)00076-8 · Cited by 725
Grant, B. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01134-k · Cited by 686
Self-citationGrant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Ruan, W. J., & Pickering, R. P. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.4.361 · Cited by 644
Self-citation
Cited by
Items 201–300 of 933
Studying Sex Differences in Animal Models of Addiction: An Emphasis on Alcohol-Related Behaviors
Hilderbrand, E. R., & Lasek, A. W. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00449 · Cited by 58
Votaw, V. R., Pearson, M. R., Stein, E., & Witkiewitz, K. A. (2020) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14283 · Cited by 59
“As compared to men with substance use disorders, women tend to have more co-morbid psychiatric disorders, endorse more coping motives for drinking, and demonstrate stronger relationships between negative affect and substance use (Conway et al., 2006; McHugh et al., 2018, 2017).”
ResultCarroll, F. I. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1441.015 · Cited by 61
Wolitzky-Taylor, K., Operskalski, J. T., Ries, R., Craske, M. G., & Roy-Byrne, P. (2011) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e31823276d7 · Cited by 54
“(Conway et al., 2006).”
BackgroundInfluentialPetit, G., Luminet, O., Uva, M. C. D. S., Monhonval, P., Leclercq, S., Quentin, S., Zammit, F., Maurage, P., & de Timary, P. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13292 · Cited by 62
Impaired periamygdaloid-cortex prodynorphin is characteristic of opiate addiction and depression
Anderson, S. A. R., Michaelides, M., Zarnegar, P., Ren, Y., Fagergren, P., Thanos, P. K., Wang, G., Bannon, M. J., Neumaier, J. F., Keller, É., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70395 · Cited by 56
“The high comorbidity rate of these disorders has been hypothesized to be due to overlapping neurobiological abnormalities in neural circuits regulating emotion (4, 5).”
Low dispositional mindfulness predicts self-medication of negative emotion with prescription opioids
Garland, E. L., Hanley, A. W., Thomas, E. A., Knoll, P., & Ferraro, J. (2015) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000090 · Cited by 52
“Several studies have demonstrated a correlation between prescription drug dependence with depression and anxiety symptoms (McCabe et al., 2005; Conway et al., 2006; Dowling et al., 2006; Huang et al., 2006), and early prevalence estimates indicated that 45% of individuals with prescription opioid use disorders met ful…”
BackgroundAdolescence and Alcohol: a review of the literature
Skala, K., & Walter, H. (2013) · Neuropsychiatrie · doi:10.1007/s40211-013-0066-6 · Cited by 66
Wolff, S., Holl, J., Stopsack, M., Arens, E. A., Höcker, A., Staben, K. A., Hiller, P., Klein, M., Schäfer, I., Barnow, S., et al. (2016) · European Addiction Research · doi:10.1159/000447397 · Cited by 52
Oliva, F., Nibbio, G., Vizzuso, P., Sodano, A. J., Ostacoli, L., Carletto, S., & Picci, R. L. (2018) · European Addiction Research · doi:10.1159/000490046 · Cited by 59
Flourish: A Strengths-Based Approach to Building Student Resilience
Rashid, T., Louden, R., Wright, L., Chu, R., Maharaj, A., Hakim, I., Uy, D., & Kidd, B. (2017) · Springer eBooks · doi:10.1007/978-3-319-51787-2_3 · Cited by 53
Completed Suicide Among Methamphetamine Users: A National Study
Darke, S. G., Kaye, S. S., Duflou, J. A., & Lappin, J. (2018) · Suicide and Life-Threatening Behavior · doi:10.1111/sltb.12442 · Cited by 59
AL-Asadi, A. M., Klein, B., & Meyer, D. (2015) · Journal of Medical Internet Research · doi:10.2196/jmir.4143 · Cited by 50
“Finally, the substance use by individuals with psychological disorders has long been investigated [36,63,64].”
The Internet-Based MGS2 Control Sample: Self Report of Mental Illness
Sanders, A. R., Levinson, D. F., Duan, J., Dennis, J. M., Li, R., Kendler, K. S., Rice, J. P., Shi, J., Mowry, B. J., Amin, F., et al. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09071050 · Cited by 50
“…epidemiological surveys (for all ancestries combined), for the Epidemiological Catchment Area (ECA) study [30], the National Comorbidity Survey (NCS) [31], the NCS Replication (NCS-R) [32, 33], and the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) – Wave I [34, 35].”
BackgroundBelujon, P., Jakobowski, N. L., Dollish, H. K., & Grace, A. A. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.191 · Cited by 54
Cranford, J. A. (2014) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2014.75.520 · Cited by 55
“The AUDADIS-IV was also used to assess lifetime and past-12-months drug use disorders (DUDs; see Conway et al., 2006; Stinson et al., 2005).”
MethodMcDermid, J., Sareen, J., El-Gabalawy, R. M., Pagura, J., Spiwak, R. P., & Enns, M. W. (2015) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2015.01.004 · Cited by 58
Substance use in youth at risk for psychosis
Carney, R., Yung, A. R., Amminger, G. P., Bradshaw, T., Glozier, N., Hermens, D. F., Hickie, I. B., Killackey, E. J., McGorry, P. D., Pantelis, C., et al. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.08.026 · Cited by 55
“Co-morbid substance use disorders are common in people with schizophrenia (Volkow, 2009), depression (Boschloo et al., 2011), and anxiety (Conway et al., 2006).”
REVIEW OF HEYMAN'SADDICTION: A DISORDER OF CHOICE
Kurti, A. N., & Dallery, J. (2012) · Journal of Applied Behavior Analysis · doi:10.1901/jaba.2012.45-229 · Cited by 53
Levitt, E. E., Oshri, A., Amlung, M. T., Ray, L. A., Sanchez‐Roige, S., Palmer, A. A., & MacKillop, J. (2022) · Psychological Medicine · doi:10.1017/s0033291721005110 · Cited by 56
Shen, M. Y. F., Perreault, M. L., Bambico, F. R., Jones-Tabah, J., Cheung, M., Fan, T., Nóbrega, J. N., & George, S. R. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.09.004 · Cited by 56
Gamble, S. A., Conner, K. R., Talbot, N. L., Yu, Q., Tu, X. M., & Connors, G. J. (2010) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2010.71.71 · Cited by 48
“However, alcohol dependence and major depression often co-occur, compounding the impact of each individual disorder (Conway et al., 2006; Hasin et al., 2007; Kessler et al., 1997; Regier et al., 1990).”
BackgroundPrevalence and correlates of alcohol use disorders in the Singapore Mental Health Survey
Subramaniam, M., Abdin, E., Vaingankar, J., Phua, A. M. Y., Tee, J., & Chong, S. A. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.03830.x · Cited by 47
Developmental Consequences of Prenatal Substance Use in Children and Adolescents
Guille, C., & Aujla, R. (2019) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2018.0177 · Cited by 57
Practical outpatient pharmacotherapy for alcohol use disorder
Kim, Y., Hack, L. M., Ahn, E. S., & Kim, J. (2018) · Drugs in Context · doi:10.7573/dic.212308 · Cited by 55
Fox, H., & Sinha, R. (2014) · Advances in Pharmacology · doi:10.1016/b978-0-12-420118-7.00006-8 · Cited by 46
McCann, D. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100503 · Cited by 46
Adán, A., Antúnez, J. M., & Navarro, J. F. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.02.035 · Cited by 46
“MARK associated with higher impairment and worse course of both disorders, worse functioning, and higher risk of suicide as compared to patients without comorbidity (Antúnez et al., 2016; Blanco et al., 2012; Conway et al., 2006; Hasin et al., 2002; Magidson et al., 2013; Worley et al., 2012).”
InfluentialChie, Q. T., Tam, C. L., Bonn, G. B., Wong, C. P., Dang, H. M., & Khairuddin, R. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00065 · Cited by 46
“Several studies have demonstrated that males were more likely to use substances for experimentation as compared to females (38), whose drug use was more highly associated with mood and anxiety disorders (39), eating disorders (40), as well as severe premenstrual syndrome or premenstrual dysphoric disorder (41).”
BackgroundPedraz, M., Araos, P. F., García‐Marchena, N., Serrano, A., Romero‐Sanchiz, P., Suárez, J., Castilla‐Ortega, E., Mayoral, F., Ruiz, J. J., Pastor, A., et al. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00017 · Cited by 56
Long-Term Effects of Peripubertal Binge EtOH Exposure on Hippocampal microRNA Expression in the Rat
Prins, S. A., Przybycien-Szymanska, M. M., Rao, Y. S., & Pak, T. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0083166 · Cited by 45
“Indeed, previous studies by our laboratory and others have demonstrated both immediate and long-term effects of repeated mid/peri-pubertal binge EtOH exposure on genes that regulate the physiological stress response [12,14,15,17,58].”
BackgroundGriffin, M. L., Dodd, D. R., Potter, J. S., Rice, L. S., Dickinson, W., Sparenborg, S., & Weiss, R. D. (2013) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2013.842241 · Cited by 52
“Participants with a co-occurring axis I psychiatric diagnosis in the present study were similar to those without a psychiatric diagnosis on sociodemographic variables other than gender: women were more likely than men to have a co-occurring diagnosis; this gender difference is consistent with results from a large epid…”
ResultGoldstein, R. B., Dawson, D. A., Chou, S. P., Ruan, W. J., Saha, T. D., Pickering, R. P., Stinson, F. S., & Grant, B. F. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0305 · Cited by 54
Self-citationTormohlen, K. N., Mojtabai, R., Seiwell, A., McGinty, E. E., Stuart, E. A., Tobin, K. E., & Troiani, V. (2021) · Journal of Dual Diagnosis · doi:10.1080/15504263.2021.1979349 · Cited by 55
“From US national survey data, lifetime prevalence of co-occurring OUD and MDD has been shown to be as high as 50–60% (Conway et al., 2006; Grella et al., 2009).”
BackgroundLeluțiu-Weinberger, C., Manu, M., Ionescu, F., Dogaru, B., Kovacs, T., Dorobănțescu, C., Predescu, M., Surace, A., & Pachankis, J. E. (2018) · JMIR mHealth and uHealth · doi:10.2196/mhealth.9283 · Cited by 44
Mahoney, J. J. (2019) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000245 · Cited by 52
Kim, T. W., Palepu, A., Cheng, D. M., Libman, H., Saitz, R., & Samet, J. H. (2007) · AIDS Care · doi:10.1080/09540120701294245 · Cited by 44
“Since mood disorders commonly occur with substance use disorders (Conway et al, 2006 ; Grant et al, 2004 ), screening and management of depression in HIV-infected adults with alcohol problems are likely to be particularly important to maximise the benefits of ART.”
BackgroundPrzybycien-Szymanska, M. M., Rao, Y. S., & Pak, T. R. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00615.2009 · Cited by 44
“Correlative studies have demonstrated that over 50% of patients with alcohol dependency also have anxiety-related or depression-related psychiatric disorders (13), and these types of disorders are often associated with an abnormal stress response.”
Robinson, J. A., Sareen, J., Cox, B. J., & Bolton, J. M. (2009) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0b013e3181c299c2 · Cited by 43
“Anxiety and substance use disorders frequently co-occur in both clinical and community populations (Conway et al., 2006; Grant et al., 2004a; Sareen et al., 2001; Smail et al., 1984).”
BackgroundAlcohol Abuse in Sickle Cell Disease: The Pisces Project
Levenson, J. L., McClish, D. K., Dahman, B. A., Penberthy, L. T., Bovbjerg, V. E., Aisiku, I. P., Roseff, S. D., & Smith, W. R. (2007) · American Journal on Addictions · doi:10.1080/10550490701525434 · Cited by 42
Schaub, M. P., Blankers, M., Lehr, D., Boss, L., Riper, H., Dekker, J., Goudriaan, A. E., Maier, L. J., Haug, S., Amann, M., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011457 · Cited by 43
Caputo, F., Francini, S., Stoppo, M., Lorenzini, F., Vignoli, T., Del Re, A., Comaschi, C., Leggio, L., Addolorato, G., Zoli, G., et al. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108094620 · Cited by 42
McCauley, J. L., Amstadter, A. B., Danielson, C. K., Ruggiero, K. J., Kilpatrick, D. G., & Resnick, H. S. (2009) · Addictive Behaviors · doi:10.1016/j.addbeh.2009.03.026 · Cited by 43
Cognitive and clinical outcomes associated with cannabis use in patients with bipolar I disorder
Braga, R. J., Burdick, K. E., DeRosse, P., & Malhotra, A. K. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.05.025 · Cited by 42
“Introduction Cannabis is the most widely used illicit substance in western countries, with lifetime prevalence of 8-12% in United States (Conway et al., 2006; Stinson et al., 2006).”
BackgroundOsilla, K. C., Hepner, K. A., Muñoz, R. F., Woo, S. M.-L., & Watkins, K. E. (2009) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2009.04.006 · Cited by 49
Casaletto, K. B., Obermeit, L. C., Morgan, E. E., Weber, E., Franklin, D. R., Grant, I., & Woods, S. P. (2014) · Addictive Behaviors · doi:10.1016/j.addbeh.2014.08.007 · Cited by 47
Locomotor response to novelty as a predictor of reactivity to aversive stimuli in the rat
White, D. A., Kalinichev, M., & Holtzman, S. G. (2007) · Brain Research · doi:10.1016/j.brainres.2007.02.050 · Cited by 44
“depression) have been well-documented in humans (Kokkevi and Stefanis, 1995;Grant, 1995;Merikangas et al., 1998;Conway et al., 2006).”
BackgroundInfluentialMethodological Issues in Assessing the Impact of Prenatal Drug Exposure
Konijnenberg, C. (2015) · Substance Abuse Research and Treatment · doi:10.4137/sart.s23544 · Cited by 61
Leal, I. M., Taing, M., Correa-Fernández, V., Obasi, E. M., Kyburz, B., Le, K., Koshy, L., Chen, T. A., Williams, T., Casey, K., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18115764 · Cited by 46
“Additionally, compared to their male counterparts, women with SUDs face greater challenges addressing tobacco dependence due to higher lifetime rates of mood and anxiety disorders [16].”
BackgroundGlover‐Wright, C., Coupe, K., Campbell, A. C., Keen, C., Lawrence, P., Kinner, S. A., & Young, J. T. (2023) · Drug and Alcohol Review · doi:10.1111/dar.13651 · Cited by 46
“Substance use disorder and mental illness frequently co-occur [1, 2], can arise simultaneously or sequentially [3, 4] and are strongly associated, whereby the presence of one of these conditions increases the likelihood of developing the other [5, 6].”
BackgroundNewman, A. H., Xi, Z., & Heidbreder, C. A. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_347 · Cited by 42
Wojcik, S. M., Tantra, M., Stepniak, B., Man, K. N. M., Ribbe, K., Begemann, M., Ju, A., Papiol, S., Ronnenberg, A., Gurvich, A., et al. (2013) · Molecular Medicine · doi:10.2119/molmed.2013.00033 · Cited by 44
SARA: a mobile app to engage users in health data collection
Rabbi, M., Philyaw-Kotov, M. L., Lee, J. S., Mansour, A., Dent, L. M., Wang, X., Cunningham, R. M., Bonar, E. E., Nahum-Shani, I. B., Klasnja, P., et al. (2017) · ACM International Joint Conference on Pervasive and Ubiquitous Computing (UbiComp) · doi:10.1145/3123024.3125611 · Cited by 44
“Furthermore, substance use frequently co-occurs with depression and other mental illnesses, which may further reduce motivation to engage [26].”
BackgroundHazardous alcohol use among patients with schizophrenia and depression
Subramaniam, M., Mahesh, M. V., Peh, C. X., Tan, J., Fauziana, R., Satghare, P., Gupta, B., Kandasami, G., & Chong, S. A. (2017) · Alcohol · doi:10.1016/j.alcohol.2017.07.008 · Cited by 47
Harrington, M., Robinson, J., Bolton, S.-L., Sareen, J., & Bolton, J. M. (2011) · The Canadian Journal of Psychiatry · doi:10.1177/070674371105601107 · Cited by 38
Mutumba, M., & Harper, G. W. (2015) · Journal of the International AIDS Society · doi:10.7448/ias.18.2.19429 · Cited by 47
“Studies have consistently reported higher rates of MHDs such as major depression, anxiety, conduct disorder, attentiondeficit/hyperactivity disorder (ADHD), substance use disorder, alcohol dependence and abuse, suicide, and post-traumatic stress disorder (PTSD) among sexual minority youth [24 28], gender minority yout…”
BackgroundLevin, M. E., Dalrymple, K., & Zimmerman, M. (2014) · Psychology of Addictive Behaviors · doi:10.1037/a0034706 · Cited by 36
Yrondi, A., Aouizerate, B., Bennabi, D., Richieri, R., D'Amato, T., Bellivier, F., Bougerol, T., Horn, M., Camus, V., Courtet, P., et al. (2020) · Depression and Anxiety · doi:10.1002/da.22997 · Cited by 37
Zullig, K. J., Divin, A. L., Weiler, R. M., Haddox, J. D., & Pealer, L. N. (2015) · Substance Use & Misuse · doi:10.3109/10826084.2015.1027931 · Cited by 45
“…Hall et al. (2010) found that adolescents with higher levels of anxiety and depression reported significantly more NMUPDep than their counterparts; Conway et al. (2006) found that almost 50% of those with depressant use disorders suffered from depression; Grant (1995) reported that individuals…”
BackgroundPorreca, A., Biringen, Z., Parolin, M., Saunders, H., Ballarotto, G., & Simonelli, A. (2018) · BioMed Research International · doi:10.1155/2018/5359037 · Cited by 37
“Individuals with SUD often report symptoms in additional areas of psychopathology, suggesting that there is significant comorbidity of substance use with other areas of dysfunction [31, 32].”
BackgroundEffects of opioids on the parental brain in health and disease
Swain, J. E., Ho, S.-H. S., Fox, H. C., Garry, D. J., & Brummelte, S. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100766 · Cited by 38
“Addressing this gap is challenging because of the common co-morbidities of depression (Conway et al., 2006; Davis et al., 2017) and polysubstance use (Substance Abuse and Mental Health Services Administration, 2009) that may mask the effects of BT in OUD discussed above.”
BackgroundVirtanen, S., Kuja‐Halkola, R., Mataix‐Cols, D., Jayaram‐Lindström, N., D'Onofrio, B. M., Larsson, H., Rück, C., Suvisaari, J., Lichtenstein, P., & Latvala, A. (2019) · Psychological Medicine · doi:10.1017/s0033291719001788 · Cited by 40
“Potential sex differences in the comorbidity also remain poorly understood, as some studies report no differences (Swendsen et al., 1998; Farrell et al., 2001; Conway et al., 2006), whereas others find stronger associations among women (Farrell et al.”
BackgroundResultInfluentialDeji, C., Yan, P., Ji, Y., Yan, X., Feng, Y., Liu, J., Liu, Y., Wei, S., Zhu, Y., & Lai, J. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.894886 · Cited by 40
“Individuals with stress or anxiety disorders are particularly vulnerable to opioid addiction (Conway et al., 2006).”
BackgroundInter-observer reliability of DSM-5 substance use disorders
Denis, C. M., Gelernter, J., Hart, A. B., & Kranzler, H. R. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.05.019 · Cited by 36
“Consistent with the results of other studies, we found that SUDs commonly cooccurred with other SUDs (Regier et al., 2013; Stinson et al., 2005) and psychiatric disorders (Compton et al., 2007; Conway et al., 2006).”
ResultGlial Cell Line-Derived Neurotrophic Factor (GDNF) as a Novel Candidate Gene of Anxiety
Kótyuk, E., Keszler, G., Németh, N., Rónai, Z., Sasvári‐Székely, M., & Székely, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080613 · Cited by 40
“Since mood disorders are often accompanied by drug abuse [28], and impaired dopaminergic signaling is a well-known factor in the pathogenesis”
BackgroundCancer incidence in people with affective disorder: nationwide cohort study in Taiwan, 1997–2010
Hung, Y., Yang, S.-Y., Huang, M., Lung, F., Lin, S., Chen, K., Kuo, C., & Chen, Y. (2014) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.114.144741 · Cited by 38
Nelemans, S. A., Hale, W. W., Raaijmakers, Q. A. W., Branje, S. J. T., van Lier, P. A. C., & Meeus, W. H. J. (2016) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-015-0747-8 · Cited by 36
“These studies are characterized by psychiatric comorbidity rates in epidemiological samples [19, 20], studies that involve current cannabis users only [21], studies that focus on cannabis use problems and dependence rather than use in itself [22], and studies with undergraduate or adult samples (see [23] for a compara…”
López‐Castromán, J., Jaussent, I., Béziat, S., Genty, C., Olié, É., de León-Martínez, V., Baca‐García, E., Malafosse, A., Courtet, P., & Guillaume, S. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.04.025 · Cited by 44
Blanco, C., Rubio, J. M., Wall, M., Secades-Villa, R., Beesdo-Baum, K., & Wang, S. (2014) · Depression and Anxiety · doi:10.1002/da.22139 · Cited by 36
“Among individuals who had GAD-MDD, 17.8% had GAD onset before MDD, 36.7% had the onset of MDD prior to GAD, 41.6% had in the same year, and in 3.9% the order of onset was unknown (Data not shown).”
InfluentialTrojak, B., Sauvaget, A., Fecteau, S., Lalanne, L., Chauvet‐Gélinier, J., Koch, S., Bulteau, S., ZULLINO, D. F., & Achab, S. (2017) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.16080147 · Cited by 39
“This is relevant because compared with the general population, people addicted to drugs are roughly twice as likely to suffer from mood and anxiety disorders.(58) Moreover, rTMS and tDCS may be efficacious for the treatment of depressive disorders and anxiety disorders.”
BackgroundThe reciprocal lagged effects of substance use and recidivism in a prisoner reentry context
Link, N. W., & Hamilton, L. (2017) · Health & Justice · doi:10.1186/s40352-017-0053-2 · Cited by 47
Addressing Unhealthy Substance Use in Primary Care
Pace, C. A., & Uebelacker, L. A. (2018) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.02.004 · Cited by 41
“Further, more than 40% of persons with an SUD have a mood disorder and about a third have an anxiety disorder.(22)”
BackgroundGender Differences in the Outcome of Offspring Prenatally Exposed to Drugs of Abuse
Traccis, F., Frau, R., & Melis, M. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.00072 · Cited by 40
“Women also exhibit higher prevalence rates of comorbidity with other psychiatric disorders as well as of relapse (Wilcox and Yates, 1993; Conway et al., 2006; Back et al., 2011; Khan et al., 2013).”
BackgroundJegede, O., Rhee, T. G., Stefanovics, E. A., Zhou, B., & Rosenheck, R. A. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114720 · Cited by 34
Motta‐Ochoa, R., Bertrand, K., Arruda, N., Jutras‐Aswad, D., & Roy, É. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.07.012 · Cited by 36
Pro, G. C., & Zaller, N. D. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228755 · Cited by 39
Emotion Regulation Diversity in Current and Remitted Depression
Wen, A., Quigley, L., Yoon, K. L., & Dobson, K. S. (2021) · Clinical Psychological Science · doi:10.1177/2167702620978616 · Cited by 38
Tourjman, V., Buck, G., Jutras‐Aswad, D., Khullar, A., McInerney, S. J., Saraf, G., Pinto, J. V., Potvin, S., Poulin, M.-J., Frey, B. N., et al. (2022) · The Canadian Journal of Psychiatry · doi:10.1177/07067437221099769 · Cited by 46
“7%).(23) Other factors may influence the prevalence of CU in BD.”
BackgroundContingency management treatments decrease psychiatric symptoms.
Petry, N. M., Alessi, S. M., & Rash, C. J. (2013) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0032499 · Cited by 33
Is subclinical gambling really subclinical?
Weinstock, J., April, L. M., & Kallmi, S. (2017) · Addictive Behaviors · doi:10.1016/j.addbeh.2017.05.014 · Cited by 38
The Age of Onset of Anxiety Disorders
Legerstee, J. S., Dierckx, B., Utens, E. M. W. J., Verhulst, F. C., Zieldorff, C., Dieleman, G. C., & de Lijster, J. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-72619-9_7 · Cited by 38
Caputo, F., Francini, S., Brambilla, R., Vigna‐Taglianti, F., Stoppo, M., Re, A. D., Leggio, L., Addolorato, G., Zoli, G., & Bernardi, M. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.12.005 · Cited by 34
“Psychiatric co-morbidity is currently described in 30–50% of alcoholic patients following a rehabilitation program (Grant et al., 2004; Kessler, 2004; Conway et al., 2006; Queyen and Mausbach, 2007).”
BackgroundIllicit use of pharmaceutical opioids among young polydrug users in Ohio
Daniulaityte, R., Falck, R. S., Wang, J., & Carlson, R. G. (2009) · Addictive Behaviors · doi:10.1016/j.addbeh.2009.03.037 · Cited by 35
Co-occurrence patterns of anxiety, depression and alcohol use disorders
Filho, N. D. A., Lessa, Í., Magalhães, L. B. N. C., Araújo, M. J., Aquino, E. M. L., & Mari, J. D. J. (2007) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-007-0752-0 · Cited by 35
“... National Comorbidity Survey [31], the OPCS National Psychiatric Morbidity Survey [20], the International Consortium in Psychiatric Epidemiology [39], the Australian National Survey of Mental Health and Well Being [6], the Netherlands Mental Health Survey and Incidence Study [19], the Zurich Cohort Study [11, 40],…”
Wu, L.-T. T., Gersing, K. R., Swartz, M. S., Burchett, B. M., Li, T., & Blazer, D. G. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.12.009 · Cited by 35
“Survey data estimate that 41% of American adults with a history of drug use disorder have a history of MD (Conway et al., 2006).”
BackgroundStimulant use disorders: Characteristics and comorbidity in an Australian population sample
Sara, G. E., Burgess, P. M., Harris, M., Malhi, G. S., Whiteford, H., & Hall, W. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412461057 · Cited by 34
“We therefore could not examine individual stimulant drugs, when there is evidence that personal correlates, harms and risks of dependence do differ amongst different types of stimulants (Conway et al., 2006; Grant, 1995; McKetin et al., 2006a).”
BackgroundReconsidering depression as a risk factor for substance use disorder: Insights from rodent models
Rappeneau, V., & Bérod, A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.04.001 · Cited by 36
“For instance, prevalence rates of SUD are almost twice as high among individuals with severe depression compared to the general population (Conway et al., 2006; Grant et al., 2016; Swendsen et al., 2010; for review Tolliver and Anton, 2015).”
Smoking Among Pregnant Women in Outpatient Treatment for Opioid Dependence: A Qualitative Inquiry
Fallin‐Bennett, A., Miller, A., & Ashford, K. B. (2016) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntw023 · Cited by 33
Cyclic nucleotide phosphodiesterases: potential therapeutic targets for alcohol use disorder
Wen, R.-T., Zhang, F.-F., & Zhang, H. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4895-7 · Cited by 34
“…other hand, anhedonic or dysphoric states, such as anxiety and depression, which may be due to pre-existing conditions or abrupt cessation of repeated alcohol consumption, may account for the motivational aspects of alcohol abuse and relapse (Conway et al. 2006; Koob and Le Moal 1997; Pandey 2003).”
BackgroundMirtazapine attenuates anxiety- and depression-like behaviors in rats during cocaine withdrawal
Méndez, S. B., & Salazar‐Juárez, A. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119840521 · Cited by 33
Zhai, T., Salmeron, B. J., Gu, H., Adinoff, B. H., Stein, E. A., & Yang, Y. (2021) · Brain Communications · doi:10.1093/braincomms/fcab120 · Cited by 34
“, 2014), which are often co-occurring with SUD (Conway et al., 2006), it would seem critical to better understand the functional circuitry that enables this large, heterogeneous brain region such a prominent role.”
Magidson, J. F., Wang, S., Lejuez, C. W., Iza, M., & Blanco, C. (2013) · Depression and Anxiety · doi:10.1002/da.22122 · Cited by 31
Rieckmann, T. R., Muench, J., McBurnie, M. A., Leo, M. C., Crawford, P. M., Ford, D., Stubbs, J., O’Cleirigh, C. M., Mayer, K. H., Fiscella, K. A., et al. (2016) · Substance Abuse · doi:10.1080/08897077.2016.1189477 · Cited by 34
Frick, A., Ahs, F., Linnman, C., Jonasson, M., Appel, L., Lubberink, M., Långström, B., Fredrikson, M., & Furmark, T. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.92 · Cited by 30
Alcohol and Drug Use, Smoking, and Gambling among Psychiatric Outpatients: A 1-Year Prevalence Study
Nehlin, C., Grönbladh, L., Fredriksson, A., & Jansson, L. (2013) · Substance Abuse · doi:10.1080/08897077.2012.728991 · Cited by 35
Gubatan, J. M. B., Staller, K. D., Barshop, K., & Kuo, B. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4090-9 · Cited by 32
“Likewise, comorbid psychiatric disorders were estimated to be about 60 %, but could be as high as 90 % in patients with cannabis dependence [31, 32].”
BackgroundThe Developmental Origins of Opioid Use Disorder and Its Comorbidities
Levis, S. C., Mahler, S. V., & Baram, T. Z. (2021) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2021.601905 · Cited by 38
Aggarwal, M., Banerjee, A., Singh, S. M., Mattoo, S. K., & Basu, D. (2012) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2011.11.008 · Cited by 32
Green, M., & Rempel, M. (2012) · Journal of Drug Issues · doi:10.1177/0022042612446592 · Cited by 30
McHugh, R. K., Votaw, V. R., Barlow, D. H., Fitzmaurice, G. M., Greenfield, S. F., & Weiss, R. D. (2017) · Contemporary Clinical Trials · doi:10.1016/j.cct.2017.07.006 · Cited by 33
“More than 60% of those with opioid dependence meet criteria for a lifetime anxiety disorder [4], and anxiety symptoms are associated with poorer quality of life [5], treatment dropout [6], and abuse of other substances (e.”
Metadata
- Authors
- Conway, K. P., Compton, W., Stinson, F. S., & Grant, B. F.
- Affiliations
- National Institutes of Health (US)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2006-02-15
- Volume
- 67
- Issue
- 02
- Pages
- 247-258
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2059057223
- Cited by
- 934
- References
- 24
- Citations by year
- 2026: 25 · 2025: 42 · 2024: 44 · 2023: 35 · 2022: 56 · 2021: 56 · 2020: 83 · 2019: 38 · 2018: 51 · 2017: 55 · 2016: 53 · 2015: 63 · 2014: 55 · 2013: 56 · 2012: 45
- FWCI
- 24.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- psychiatric comorbidity, mood disorders, anxiety disorders, drug use disorders, substance dependence, substance abuse, lifetime prevalence, sex differences, DSM-IV, illicit drug use
- MeSH terms
- Adolescent, Adult, Alcoholism, Anxiety Disorders, Depressive Disorder, Female, Health Surveys, Humans, Male, Psychiatric Status Rating Scales, Regression Analysis, Sex Factors, United States, Comorbidity, Prevalence, Diagnosis, Dual (Psychiatry), Mood Disorders, Substance-Related Disorders, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.